These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25650544)

  • 1. Access to 'investigational' cancer drugs: perspective of a trainee.
    Kuo JC
    Intern Med J; 2015 Feb; 45(2):235. PubMed ID: 25650544
    [No Abstract]   [Full Text] [Related]  

  • 2. Dilemmas in the compassionate supply of investigational cancer drugs.
    Lewis JR; Lipworth W; Kerridge I; Doran E
    Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded Access Allows for Compassionate Use of Investigational Cancer Drugs.
    Miller D
    ONS Connect; 2015 Jun; 30(2):47. PubMed ID: 26137830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Second Opinion, Compassionate Use, and Clinical Trial].
    Sanz Rubiales Á; Fernández González M
    Cuad Bioet; 2017; 28(92):127-128. PubMed ID: 28342439
    [No Abstract]   [Full Text] [Related]  

  • 5. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

  • 6. Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs.
    Bunnik EM; Aarts N; van de Vathorst S
    Health Policy; 2018 Sep; 122(9):977-983. PubMed ID: 29935731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ethical framework for the creation, governance and evaluation of accelerated access programs.
    Pace J; Ghinea N; Kerridge I; Lipworth W
    Health Policy; 2018 Sep; 122(9):984-990. PubMed ID: 30055901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One Last Shot.
    Berlin J
    Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
    Jacob JA
    JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
    [No Abstract]   [Full Text] [Related]  

  • 10. Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program.
    Feit NZ; Goldman DA; Smith E; Deighan J; Iasonos A; Zivanovic O; Hyman DM
    JAMA Oncol; 2019 Apr; 5(4):570-572. PubMed ID: 30816938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical concerns regarding private equity in Right to Try in the USA.
    Lee SW; Hurst DJ
    Lancet Oncol; 2020 Oct; 21(10):1260-1262. PubMed ID: 33002434
    [No Abstract]   [Full Text] [Related]  

  • 12. Accessing investigational anticancer agents outside of clinical trials.
    Montello MJ; Greenblatt JJ; Fallavollita A; Shoemaker D
    Am J Health Syst Pharm; 1998 Apr; 55(7):651-2, 660. PubMed ID: 9558419
    [No Abstract]   [Full Text] [Related]  

  • 13. Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials.
    Caplan AL; Teagarden JR; Kearns L; Bateman-House AS; Mitchell E; Arawi T; Upshur R; Singh I; Rozynska J; Cwik V; Gardner SL
    J Med Ethics; 2018 Nov; 44(11):761-767. PubMed ID: 29982174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer, access to investigational drugs, and patient rights in the U.S.A. and India.
    Sheehan HE
    Indian J Med Ethics; 2008; 5(4):170-2; discussion 173. PubMed ID: 18988376
    [No Abstract]   [Full Text] [Related]  

  • 16. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
    Hoerger M
    Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients in need be given access to experimental drugs?
    Caplan AL; Bateman-House A
    Expert Opin Pharmacother; 2015 Jun; 16(9):1275-9. PubMed ID: 26001178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID-19.
    Aliu P; Sarp S; Fitzsimmons P
    Clin Pharmacol Ther; 2021 Jul; 110(1):26-28. PubMed ID: 33326600
    [No Abstract]   [Full Text] [Related]  

  • 19. "Right to Try" Laws: The Gap between Experts and Advocates.
    Dresser R
    Hastings Cent Rep; 2015; 45(3):9-10. PubMed ID: 25944200
    [No Abstract]   [Full Text] [Related]  

  • 20. Before It's Too Late: Multistakeholder Perspectives on Compassionate Access to Investigational Drugs for Pediatric Patients With Cancer.
    Gerasimov E; Donoghue M; Bilenker J; Watt T; Goodman N; Laetsch TW
    Am Soc Clin Oncol Educ Book; 2020 May; 40():1-10. PubMed ID: 32412804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.